2018
DOI: 10.2174/1389201019666180322111800
|View full text |Cite
|
Sign up to set email alerts
|

Caffeoylquinic Acids Rich versus Poor Fractions of Gynura procumbens: Their Comparative Antihyperlipidemic and Antioxidant Potential

Abstract: The resin separation technology may find application in caffeoylquinic acids enrichment of plant extracts for pre-clinical studies. The F2 has potential for development into phytopharmaceuticals as adjunct therapy for management of hyperlipidemia.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
4
0

Year Published

2019
2019
2023
2023

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 6 publications
(4 citation statements)
references
References 0 publications
0
4
0
Order By: Relevance
“…In the case of hyperlipidemia, a typical indicator of the rise of oxidative stress in the heart, it is closely linked to the overproduction of ROS and a damaged antioxidant defense system (34), and the disrupted balance between ROS generation and the ROS scavenging system will result in intracellular formation and accumulation of superoxide ions, leading to dysfunction and cell damage (35). Considering that the elevated ROS levels cause strong injurious effects on hyperlipidemia patients, nowadays, various types of antioxidant agents have been investigated for their potential in the treatment of hyperlipidemia (36).…”
Section: Discussionmentioning
confidence: 99%
“…In the case of hyperlipidemia, a typical indicator of the rise of oxidative stress in the heart, it is closely linked to the overproduction of ROS and a damaged antioxidant defense system (34), and the disrupted balance between ROS generation and the ROS scavenging system will result in intracellular formation and accumulation of superoxide ions, leading to dysfunction and cell damage (35). Considering that the elevated ROS levels cause strong injurious effects on hyperlipidemia patients, nowadays, various types of antioxidant agents have been investigated for their potential in the treatment of hyperlipidemia (36).…”
Section: Discussionmentioning
confidence: 99%
“…Therefore, fraction that rich caffeoylquinic has potential for development into phytopharmaceuticals as adjunct therapy for management of hyperlipidaemia. 8…”
Section: Caffeoylquinic Acidsmentioning
confidence: 99%
“…The di-caffeoylquinic acids are responsible for the potent antihyperlipidaemia effect. 8…”
Section: Anti-hyperlipidaemia Effectsmentioning
confidence: 99%
“…Merr. 15,16-Dihydroxy-9Z, 12Z-octadecadienoic acid (PubChem CID: 16061068) Akowuah et al (2002) , Rosidah et al (2008) , Kim et al (2011) , Kaewseejan and Siriamornpun (2015) , Murugesu et al (2017) , Li et al (2018) , Murugaiyah et al (2018) , Nazri et al (2019) , Huang et al (2019) , Liu M. et al (2019) , Liu Y. et al (2019) , Chandradevan et al (2020) 3,4-Dicaffeoylquinic acid (Isochlorogenic acid B) (PubChem CID: 5281780) 3,5-Dicaffeoylquinic acid (Isochlorogenic acid A) (PubChem CID: 6474310) 3,5-O-Dicaffeoylquinic acid (PubChem CID: 13604688) 3-O-Methyl gallic acid sulfate (PubChem CID: not found) 3-Carene (PubChem CID: 26049) 4,5-Dicaffeoylquinic acid (Isochlorogenic acids C) (PubChem CID: 6474309) 4-O-Methyl gallic acid sulfate (PubChem CID: not found) 5-O-(E)-Caffeoyl-galactaric acid (PubChem CID: not found) Apigenin (PubChem CID: 5280443) Caffeic acid (PubChem CID: 689043) Chlorogenic acid (PubChem CID: 1794427) Choline (PubChem CID: 305) Citric acid (PubChem CID: 311) Cynarine (PubChem CID: 5281769) Dicaffeoylquinic acids (PubChem CID: 6474310) Eriocitrin (PubChem CID: 83489) Ferulic acid (PubChem CID: 445858) Feruloylquinic acid (PubChem CID: 10133609) Gallic acid (PubChem CID: 370) Genkwanin isomer (PubChem CID: 5281617) Isobioquercetin (PubChem CID: not found) Kaempferol (PubChem CID: 5280863) Kaem...…”
Section: Future Perspectivementioning
confidence: 99%